The Claim
The combination of supervised exercise and liraglutide resulted in a 2.3 percentage-point greater reduction in body-fat percentage one year after treatment cessation compared to liraglutide alone, with exercise preserving lean mass and reducing fat mass during weight loss maintenance.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People who combined supervised exercise with liraglutide lost 2.3 percentage points more body fat one year after stopping treatment than those who used liraglutide alone, and they retained more muscle while losing more fat.
See the scientific wording
The combination of supervised exercise and liraglutide led to a 2.3 percentage-point greater reduction in body-fat percentage one year after treatment cessation compared to liraglutide alone, indicating that exercise improves the quality of weight loss maintenance by preserving lean mass and reducing fat mass.
When a person stops taking the weight-loss drug, their hunger increases and their body burns fewer calories, making it easy to regain fat. Regular exercise during treatment trains the body to keep burning more calories even after stopping, and it keeps muscle mass high, which helps maintain a higher metabolic rate. This prevents the body from storing excess fat when hunger rises after the drug is stopped.
What the research says
1 studyPeople who did exercise and took the weight-loss drug together lost more body fat a year after stopping than those who only took the drug — the study proved it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.